FDA approves supplemental test for Chagas disease in blood

11/22/2011 | Medscape (free registration)

The FDA has approved Abbott Laboratories' ESA Chagas assay, which can identify antibodies to Trypanosoma cruzi, the parasite that causes Chagas disease, in human serum and plasma samples. The FDA said the test is the first licensed as a supplemental test for the disease.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care